Notable
ABX196 in Combination With Nivolumab · Hepatocellular Carcinoma
Primary endpoint(s) modified
Also in this update: Primary completion date changed from estimate of Jun 30, 2021 to Apr 14, 2022; Results posted: Sep 29, 2026
Abivax S.A.Phase 1/2 NCT03897543 Registry history of NCT03897543 on ClinicalTrials.gov (opens the registry)